NEU 1.52% $12.94 neuren pharmaceuticals limited

retts syndrome, page-25

  1. 11,720 Posts.
    lightbulb Created with Sketch. 1695
    ajostu,

    An illness doesn't need to be life threatening to gain fast track approval.

    Here's what Wikipedia mentions:

    "Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious diseases and fill an unmet medical need. The purpose is to get important new drugs to the patient earlier. Fast Track addresses a broad range of serious diseases. Determining whether a disease is serious is a matter of judgment, but generally is based on whether the drug will have an impact on such factors as survival, day-to-day functioning, or the likelihood that the disease, if left untreated, will progress from a less severe condition to a more serious one."


    However, the main causes of death in Retts sufferers are directly related to Retts itself. Including seizure, aspiration and accidents (seizure and aspiration being two of the efficacy parameters in our trial).

    So an effective treatment for Retts can claim to help survival.

    cheers

    http://en.wikipedia.org/wiki/FDA_Fast_Track_Development_Program
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$12.94
Change
-0.200(1.52%)
Mkt cap ! $1.653B
Open High Low Value Volume
$13.03 $13.06 $12.75 $7.500M 581.8K

Buyers (Bids)

No. Vol. Price($)
1 2300 $12.93
 

Sellers (Offers)

Price($) Vol. No.
$12.96 2086 1
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.